The Medicine Maker | Bioprocessing

Filter by

Bioprocessing Interviews Regulation & Standards Standards & Regulation Quality & Compliance Technology & Manufacturing Sponsored

Moving Beyond Document-Based Validation

July 2, 2026

How UCB is improving traceability, audit readiness, and visibility.

1 min read

Bioprocessing Biopharma Facilities & Equipment Industry News Technology & Manufacturing

Fujifilm and HORIBA Develop Inline Raman System for Biomanufacturing

June 29, 2026

The system is designed for real-time monitoring of cell culture and purification, with Fujifilm reporting about a 10 percent yield improvement in antibody purification tests

2 min read

Fujifilm and HORIBA Develop Inline Raman System for Biomanufacturing

Bioprocessing Interviews Technology & Manufacturing Digital Technologies Quality & Compliance Regulation & Standards Sponsored

How Zealand Pharma Is Scaling Quality Without Complexity

June 29, 2026

How connected quality systems can help growing biotechs remain agile.

0 min read

How Zealand Pharma Is Scaling Quality Without Complexity

Biopharma Bioprocessing

Improving Patient Outcomes Through Conjugation Chemistry

By Daniel Pfeffer

June 22, 2026

Why CDMO innovation is key to advancing next-generation oligonucleotide therapies

4 min read

Improving Patient Outcomes Through Conjugation Chemistry

Biopharma Biopharma Industry News Research News Sponsored

This Week’s Biopharma News: New Approvals, Appeals, and AI

June 2, 2026

Datroway and Hepcludex secure notable FDA approvals, while Outlook wins its bevacizumab appeal, BioMarin reports phase 3 VOXZOGO data, and BMS partners with Anthropic

6 min read

This Week’s Biopharma News: New Approvals, Appeals, and AI

Biopharma Cell & Gene Bioprocessing Technology & Manufacturing

Breaking the “Black Box” in Bioprocessing

May 14, 2026

Why understanding titer analytics is key to faster, more reliable biologics and gene therapy development

9 min read

Breaking the “Black Box” in Bioprocessing

Biopharma Biopharma Industry News

This Week’s Biopharma News: Amgen Deepens US Manufacturing Push

May 12, 2026

The company adds $300 million to its Puerto Rico biologics site as Pfizer reports Phase 3 myeloma data, J&J advances a dual-pathway IBD antibody, and BioNTech streamlines production

6 min read